Research programme: bacteriophage therapeutics - Fraunhofer ITEM/Leibniz Institute DSMZ German Collection of Microorganisms and Cell Cultures/Charite Universitatsmedizin Berlin

Drug Profile

Research programme: bacteriophage therapeutics - Fraunhofer ITEM/Leibniz Institute DSMZ German Collection of Microorganisms and Cell Cultures/Charite Universitatsmedizin Berlin

Latest Information Update: 27 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Charite - Universitatsmedizin Berlin; Fraunhofer-Institute for Toxicology and Experimental Medicine; Leibniz-Institut DSMZ - German Collection of Microorganisms and Cell Cultures
  • Developer Charite - Universitatsmedizin Berlin
  • Class Antibacterials
  • Mechanism of Action Bacterial DNA modulators; Bacterial RNA modulators; Cell membrane modulators; Cell wall modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Research Bacterial infections

Most Recent Events

  • 09 Nov 2017 Fraunhofer Institute for Toxicology and Experimental Medicine, Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, and Charite Universitatsmedizin Berlin collaborate for the development of bacteriophage therapeutics for Bacterial infections
  • 09 Nov 2017 Early research in Bacterial infections in Germany (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top